Marian Gorecki
Fundador en Valin Technologies Ltd. .
Cargos activos de Marian Gorecki
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Pam-Bio Ltd.
Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | Director/Miembro de la Junta | 30/04/2019 | - |
Valin Technologies Ltd. | Director/Miembro de la Junta | - | - |
Director Técnico/Científico/I+D | - | - | |
Fundador | - | - |
Historial de carrera de Marian Gorecki
Antiguos cargos conocidos de Marian Gorecki.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MEDIWOUND LTD. | Director/Miembro de la Junta | 22/04/2010 | 22/06/2017 |
Fundador | 01/01/2000 | 22/06/2017 | |
Independent Dir/Board Member | 01/01/2000 | 22/06/2017 | |
VAXIL BIO LTD. | Director/Miembro de la Junta | - | 04/01/2017 |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Director/Miembro de la Junta | 01/01/2005 | 01/03/2014 |
Independent Dir/Board Member | 01/01/2005 | 01/03/2014 | |
SCIGEN LIMITED | Director/Miembro de la Junta | 15/03/2010 | 03/03/2011 |
Weizmann Institute of Science | Corporate Officer/Principal | 01/01/1982 | 01/01/1986 |
SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | - | - |
Thrombotech Ltd.
Thrombotech Ltd. Medical SpecialtiesHealth Technology Thrombotech Ltd. is an Israel-based biotechnological company that is based on years of cutting-edge thrombotic research at the Hadassah Medical Center in Jerusalem. Thrombotech developed a peptide called THR-18, which allows the existing thrombolytic stroke medication to easily dissolve blood clots, extending its short therapeutic time window and diminishing life-threatening side effects. The company was founded in 2000 and is headquartered in Rehovot, Israel. | Presidente | 01/01/2008 | - |
Formación de Marian Gorecki.
Weizmann Institute of Science | Doctorate Degree |
Massachusetts Institute of Technology | Graduate Degree |
Estadísticas
Internacional
Israel | 7 |
Estados Unidos | 3 |
Singapur | 2 |
Operativa
Director/Board Member | 6 |
Independent Dir/Board Member | 2 |
Founder | 2 |
Sectorial
Health Technology | 8 |
Consumer Services | 2 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
MEDIWOUND LTD. | Health Technology |
VAXIL BIO LTD. | Health Technology |
Empresas privadas | 6 |
---|---|
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Health Technology |
Thrombotech Ltd.
Thrombotech Ltd. Medical SpecialtiesHealth Technology Thrombotech Ltd. is an Israel-based biotechnological company that is based on years of cutting-edge thrombotic research at the Hadassah Medical Center in Jerusalem. Thrombotech developed a peptide called THR-18, which allows the existing thrombolytic stroke medication to easily dissolve blood clots, extending its short therapeutic time window and diminishing life-threatening side effects. The company was founded in 2000 and is headquartered in Rehovot, Israel. | Health Technology |
SciGen Pte Ltd.
SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
Savient Pharmaceuticals, Inc.
Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Pam-Bio Ltd.
Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | Health Technology |
Valin Technologies Ltd. |
- Bolsa de valores
- Insiders
- Marian Gorecki
- Experiencia